Friday, February 3, 2012

First wave of speakers announced for Convergence Forum Chatham, 2012

We're excited to reveal some of the speakers who'll be joining us this May for the Convergence Forum in Chatham, Mass. They are:

· Julian Adams, PhD, President of Research & Development, Infinity Pharmaceuticals
· John Brooks III, CEO, Joslin Diabetes Center
· Michelle Dipp, MD, PhD, CEO, OvaScience; Partner, Longwood Fund
· Leonard Guarente, PhD, Novartis Professor of Biology, MIT
· Jose-Carlos Gutierrez-Ramos, PhD, SVP BioTherapeutics Research & Development, Pfizer
· Steven Holtzman, EVP of Corporate Development, Biogen Idec
· Sridhar Iyengar, PhD, Chief Technology Officer, AgaMatrix
· Reid Leonard, PhD, Managing Director, Merck Research Venture Fund
· Mark Levin, Partner, Third Rock Ventures
· Anmol Madan, PhD, Founder, Ginger.io
· David Meeker, CEO, Genzyme
· David Schafran, CEO, EyeNetra
· Philip Vickers, PhD, SVP of Research & Development, Shire Human Genetic Therapies


We hope you'll be there, too, for this ninth annual gathering of life sciences leaders.

No comments:

Post a Comment